Email Page Print Page

Fundamentals

Select the financial statements you wish to view below.  The reports below may be viewed on either an annual or quarterly basis.

NASDAQBDSI
All numbers in thousands USD
Period Ending
Dec 31, 2016
Dec 31, 2015
Dec 31, 2014
Dec 31, 2013
Total Revenue
15,546
48,231
38,944
11,356
Cost of Revenue
11,258
8,101
4,939
2,082
Gross Profit
4,288
40,130
34,005
9,274
Operating Expenses
Research Development
18,878
20,624
34,285
53,327
Selling General and Administrative
49,345
54,685
38,460
12,349
Non Recurring
--
--
--
--
Others
0
0
0
0
Total Operating Expenses
68,223
75,309
72,745
65,676
Operating Income or Loss
(63,935)
(35,179)
(38,740)
(56,402)
Income from Continuing Operations
Total Other Income/Expenses Net
64
25
(13,462)
(89)
Earnings Before Interest And Taxes
(63,935)
(35,179)
(38,740)
(56,402)
Interest Expense
--
--
--
--
Income Before Tax
(67,138)
(37,672)
(54,218)
(57,394)
Income Tax Expense
--
--
0
0
Minority Interest
--
--
--
--
Net Income From Continuing Ops
(67,138)
(37,672)
(54,218)
(57,394)
Non-recurring Events
Discontinued Operations
--
--
--
--
Extraordinary Items
--
--
--
--
Effect Of Accounting Changes
--
--
--
--
Other Items
0
0
0
0
Net Income
(67,138)
(37,672)
(54,218)
(57,394)
Preferred Stock And Other Adjustments
--
--
--
--
Net Income Applicable To Common Shares
(67,138)
(37,672)
(54,218)
(57,394)
Top News
Nov 16, 2017

BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a specialty pharmaceutical company with a focus in pain management and addiction medicine, today announced that Dr. Mark A. Sirgo, Vice...

Nov 9, 2017

BioDelivery Sciences International, Inc. (BDSI) today reported financial results for the three and nine months ended September 30, 2017, and provided an update on recent business highlights and...

Oct 30, 2017

BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that it will report its third quarter 2017 financial results and host a conference call and webcast at 4:30 PM Eastern Time on...

investor inquiries

 

Al Medwar
Senior Vice President, Corporate and Business Development
BioDelivery Sciences International, Inc.
919-582-9050
amedwar@bdsi.com